NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
Advertisement
NewsRx | Free Trials
Advertisement
----------
------------
NewsRx on Facebook
-----
Press Release Submissions
PR Login
*
*

Law & Health Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law & Health Weekly

Learn More

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now



Biopsy



Advanced Imaging Technologies to Limit Breast and GI Biopsy Procedures



November 29th, 2008

According to Millennium Research Group's (MRG's) US Markets for Biopsy Devices 2009 report, the popularity of advanced imaging technologies will restrict the number of gastrointestinal (GI) and breast biopsy procedures performed through 2013.

The availability of endoscopes with microscopic capabilities for visualizing tissue at the cellular level has decreased the requirement for a biopsy in endoscopic GI procedures. PENTAX's Confocal Endomicroscope, for example, enables physicians to examine inner structures at extreme magnifications, in some cases allowing for diagnosis without the need for a biopsy. Should additional competitors enter the endomicroscopy market, unit...


Source: Law & Health Weekly (2008-11-29)

NewsRx Passes
Advertisement
More Articles

Related Topics

------------------------
Security by Verisign PR Login